Sun, 29-May-2022

Disease

FDA Approves Roche’s Tecentriq Plus Chemotherapy f...

Roche announced that the US Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) in combination with chemotherapy (Abraxane [paclitaxel protein-bound; nab-paclitaxel] and carboplatin) for the i... December 4, 2019 9:21 am By Neha Mule

Biomica to Collaborate With Weizmann Institute of Sc...

Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd., has announced a collaboration with the Weizmann Institute of Science to dev... October 29, 2019 2:21 pm By Meeta Ramnani

1 6 7 8

Related News